Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
191 studies found for:    "Muscular Dystrophy, Duchenne"
Show Display Options
Rank Status Study
21 Completed Safety Study of Flavocoxid in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: Flavocoxid
22 Active, not recruiting Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: Epigallocatechin-Gallate;   Drug: Placebo
23 Recruiting Study of DS-5141b in Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: DS-5141b
24 Completed
Has Results
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
Conditions: Muscular Dystrophy, Duchenne;   Ambulatory Care
Interventions: Drug: Placebo;   Drug: Idebenone
25 Completed Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: PTC124
26 Not yet recruiting Analysis of a Virtual Reality Task in Patients With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Device: Acquisition on TouchScreen;   Device: Acquisition on Kinect;   Device: Acquisition on LeapMotion
27 Recruiting Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping
Condition: Duchenne Muscular Dystrophy
Intervention:
28 Active, not recruiting Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: IGF-1;   Other: Standard steroid treatment
29 Completed L-citrulline and Metformin in Duchenne's Muscular Dystrophy
Condition: Duchenne's Muscular Dystrophy (DMD)
Interventions: Drug: 750 mg metformin and 7.5 g L-citrulline daily p.o.;   Drug: Placebo
30 Recruiting Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: (+)- Epicatechin
31 Terminated Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD)
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: PRO044 SC 6 mg/kg;   Drug: PRO044 IV 6 mg/kg;   Drug: PRO044 IV 9 mg/kg
32 Completed Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: AVI-4658 (PMO)
33 Recruiting Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy
Condition: Muscular Dystrophy, Duchenne
Intervention: Drug: Translarna
34 Completed Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy
Condition: Muscular Dystrophy, Duchenne
Intervention: Drug: Pentoxifylline
35 Withdrawn A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy (DMD)
Interventions: Drug: Prednisone;   Drug: Placebo
36 Terminated Phase IIb Study of PRO045 in Subjects With Duchenne Muscular Dystrophy
Condition: Duchenne Muscular Dystrophy
Interventions: Drug: PRO045, 0.15 mg/kg/week;   Drug: PRO045, 1.0 mg/kg/week;   Drug: PRO045, 3.0 mg/kg/week;   Drug: PRO045, 6.0 mg/kg/week;   Drug: PRO045, 9.0 mg/kg/week;   Drug: PRO045, selected dose
37 Completed An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy
Condition: Muscular Dystrophy, Duchenne
Intervention: Drug: Coenzyme Q10
38 Completed
Has Results
DART Electrical Impedance Myography (EIM) Trial in Duchenne Muscular Dystrophy (DMD) and Healthy Controls
Condition: Duchenne Muscular Dystrophy
Intervention: Other: Testing with EIM
39 Completed Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)
Condition: Duchenne Muscular Dystrophy
Intervention: Drug: Idebenone
40 Completed The PTC124 (Ataluren) Clinical Trial for Duchenne Muscular Dystrophy: Exploration of the Experiences of Parents, Clinician Researchers, and the Industry Sponsor
Condition: Duchenne Muscular Dystrophy
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.